Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

17.77
+0.52003.01%
Post-market: 17.70-0.0700-0.39%19:57 EDT
Volume:11.58M
Turnover:204.00M
Market Cap:20.38B
PE:-15.55
High:17.83
Open:17.58
Low:17.34
Close:17.25
Loading ...

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

Insider Monkey
·
08 Apr

BRIEF-Biosimilar Epysqli® (Eculizumab-Aagh) Injection Now Available In The United States

Reuters
·
07 Apr

Teva Rolls Out Lower-Cost Soliris Biosimilar in US

MT Newswires Live
·
07 Apr

Teva, Samsung Bioepis announce EPYSQLI availability in the U.S.

TIPRANKS
·
07 Apr

Teva Pharmaceutical Industries Says US FDA Accepted its sBLA Filing for AJOVY

MT Newswires Live
·
07 Apr

Teva Pharmaceutical Industries Ltd - Epysqli Available at 30% Discount to Soliris Wac

THOMSON REUTERS
·
07 Apr

Teva and Samsung Bioepis Announce Biosimilar Epysqli® (Eculizumab-Aagh) Injection NOW Available in the United States

THOMSON REUTERS
·
07 Apr

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States

GlobeNewswire
·
07 Apr

Teva announces FDA acceptance of sBLA for AJOVY

TIPRANKS
·
07 Apr

Top Stock Reports for Cisco, Caterpillar & CME

Zacks
·
04 Apr

Teva Pharmaceuticals : UBS Cuts Target Price to $24 From $27

THOMSON REUTERS
·
01 Apr

Teva Says Schizophrenia Trial Survey Results Show Patient Satisfaction With TEV-'749

MT Newswires Live
·
01 Apr

Teva announces presentation of survey study on TEV-‘749

TIPRANKS
·
01 Apr

Teva Pharmaceutical's Upcoming Cost-Optimization Plan May Offer Significant Benefits, UBS Says

MT Newswires Live
·
31 Mar

Piper Sandler Keeps Their Buy Rating on Teva Pharmaceutical (TEVA)

TIPRANKS
·
31 Mar

Teva Releases Q1 2025 Aide Memoire

THOMSON REUTERS
·
28 Mar

Press Release: Teva Releases Q1 2025 Aide Memoire

Dow Jones
·
28 Mar

Teva Pharmaceuticals Is Maintained at Buy by B of A Securities

Dow Jones
·
06 Mar

Teva price target lowered to $20 from $23 at BofA

TIPRANKS
·
06 Mar

Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Teva Pharmaceutical (TEVA) and Incyte (INCY)

TIPRANKS
·
06 Mar